Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Toby Moore

Orthopaedic Surgery Galena, KS Doctor of Osteopathy

NPI 1235321381 CMS profile 56317

444 Four States Dr Ste 1, Galena, KS 66739

Open in the dashboard

General payments

$11,478

118 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Toby Moore of Galena, KS is reported in the CMS Open Payments database as having received $11,478 across 118 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,444 30
2024 General $2,596 22
2023 General $929 7
2022 General $243 6
2021 General $1,345 26
2020 General $490 7
2019 General $2,432 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Toby Moore
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Toby Moore were reported at $3,444. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Toby Moore Orthopaedic Surgery median Middle half National median
2019 $2,432 $644 $140–$2,844 $163
2020 $490 $312 $75–$1,860 $114
2021 $1,345 $520 $117–$2,495 $132
2022 $243 $598 $128–$2,731 $149
2023 $929 $461 $128–$2,264 $160
2024 $2,596 $497 $134–$2,475 $164
2025 $3,444 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $6,230 57 payments
  2. Alphatec Spine, Inc $2,496 19 payments
  3. Stryker Corporation $1,792 26 payments
  4. Augmedics Inc. $225 5 payments
  5. DePuy Synthes Sales Inc. $216 2 payments
  6. Smith+Nephew, Inc. $119 1 payment
  7. NuVasive, Inc. $100 1 payment
  8. SI-BONE, Inc. $90 1 payment
  9. OsteoCentric Technologies, Inc. $65 1 payment
  10. CoreLink, LLC $50 2 payments
  11. Other $95 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $6,572 25 payments
  2. Food and Beverage $4,766 92 payments
  3. Honoraria $140 1 payment
Products named General payments · program years 2019–2025
  1. EXCELSIUS GPS $2,391 18 payments
  2. Xvision $1,127 25 payments
  3. Other - Miscellaneous $993 4 payments
  4. ELSA Spine/Spine Surgery $903 4 payments
  5. MULTIPLE $851 5 payments
  6. ELSA, ELSA AL/ATP $668 2 payments
  7. CAPRI CORPECTOMY CAGE SYSTEM $314 6 payments
  8. ELSA Spine/Spine Surgery $275 4 payments
  9. EX NAILS $216 2 payments
  10. GAMMA $213 3 payments
  11. Other $3,128 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

122

Median for Orthopedic Surgery: 203

Drug cost

$617

Median for Orthopedic Surgery: $1,433

Branded share of claims

37.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 46 $337
Cyclobenzaprine Hcl Generic 56 $205
Gabapentin Generic 20 $75

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$140,154

Medicare's payments for the services billed

Medicare patients

297

Average age 73

Services billed

848

167 women, 130 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Ischemic heart disease 28%
Chronic kidney disease 27%
Depression 27%
COPD 24%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

118 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record